autoimmune therapy

Paris, France – April 22, 2026 In a landmark advancement for pediatric endocrinology, Sanofi has secured U.S. FDA approval...

Boston, September 29, 2025 Vor Bio has announced that late-breaking Phase 3 clinical data of telitacicept in primary Sjögren’s...

PARAMUS, NJ, September 9, 2025 — The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to...